This is the authors' abstract. We don't add key points for this paper.
Hyperglycemia is linked to many inflammatory, metabolic and malignant diseases.High glucose provides inflammatory and cancer cells with more abundant "fuel" that promotes the cell motility, proliferation and production of pro-inflammatory mediators.The "malicious behavior" of activated inflammatory cells and cancer cells is further exacerbated by over-expression of chemoattractant receptors, notably FPRs (mouse Fprs) and tyrosine kinase receptors (TKRs) that are traditionally discovered as mediators of cell migration in response to a number of pathogen and host-derived chemotactic molecular patterns (PMAPs and DAMPs) existing at the diseased sites.In addition, the M1 macrophage polarizing capacity of one of FPRs, Fpr2, acts as a double-edged sword that exacerbates the insulin resistance and obesity in high-fat diet-fed mice.Therefore, while controlling glucose to a physiological level is important, targeting cell surface FPRs and TKRs should also be critical to manage hyperglycemia-associated disease conditions.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: